Akèy › Kansè kolon › New York
Etid klinik pou Kansè kolon nan New York
28 etid pou Kansè kolon ap chèche patisipan nan sit nan New York.
Vil nan New York
Tèks ofisyèl etid la (Anglè)
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Montefiore Medical Center-Einstein Campus, The Bronx
- James J Peters VA Medical Center, The Bronx
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07283939Family Communications After Genetic Testing
- Glens Falls Hospital, Glens Falls
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Memorial Sloan Kettering Cancer Center ( Site 0095), New York
- Ellis Hospital ( Site 0098), Schenectady
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06997497Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- NYOH Albany Cancer Center, Albany
- Hematology-Oncology Associates of Central New York, PC, Auburn
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
- ak 12 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07222800Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- NYU Langone Health Perlmutter Cancer Center, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07629960A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
- Ny Cancer and Blood Specialists, Shirley
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07284849Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Ap rekrite
Laj 45 a 70 · Tout sèks · Mizajou Sep 2, 2026 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn
- The New York Hospital Medical Center of Queens, Flushing
- Glens Falls Hospital, Glens Falls
- ak 23 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05174169Shield Post-Approval Study Protocol
- Associated Gastroenterologists of Central New York, Camillus
- Syracuse Gastroenterological Associates, P.C., East Syracuse
- Associated Gastroenterologists of Central New York, Fayetteville
- ak 4 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 45 a 81 · Tout sèks · Mizajou Aug 7, 2026 · NCT06880055Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, New York
- Xencor Investigative Site, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT05433142A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center 53rd street., New York
- ak 1 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07318805EXoPERT EMERALD Clinical Study
- Albany Stratton VA Medical Center, Albany
- Bronx Veterans Medical Research Foundation, The Bronx
- VA Hudson Valley Healthcare System, Wappingers Falls
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 45 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT07186296Integrated Cancer Repository for Cancer Research
- C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
- Faxton St. Luke's Healthcare, Mohawk Valley, Utica
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- NYU Langone Medical Center, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT06051695A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, New York
- Research Site, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06835569Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT06040541Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Columbia University, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 15, 2026 · NCT05379985Brodalumab in the Treatment of Immune-Related Adverse Events
- Columbia University Irving Medical Center, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT06673329Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
- NYU Langone Health, New York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 11, 2026 · NCT00843375Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 12, 2026 · NCT04668872Phase II Trial of Lung Chemoemobolization
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 5, 2026 · NCT05672108Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
- Roswell Park Comprehensive Cancer Center, Buffalo
Ap rekriteFaz 3
Laj 1 ak plis · Tout sèks · Mizajou Feb 4, 2026 · NCT06563388Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jan 23, 2026 · NCT05855200Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- ak 1 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Jan 23, 2026 · NCT00582621Evaluation of Circulating Immune Response After Histosonics in Colorectal Cancer (ECHO-CRC)
- Zuckerberg Cancer Center, New Hyde Park
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jan 22, 2026 · NCT07361107SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- ak 2 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- NYU Langone Health, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT06682793Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.